Stephens & Co. analyst George Sellers initiates coverage on TransMedics Gr (NASDAQ:TMDX) with a Overweight rating and announces Price Target of $151.
Stephens & Co. Initiates Coverage On TransMedics Gr With Overweight Rating, Announces Price Target of $151
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.